Achal Desai, MD
Nephrology · Shawnee, KSNPI 1134123185
Payments from drug & device makers
Across 535 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calliditas Therapeutics US Inc.$1K
- Bayer$1K
- AstraZeneca$915
- OPKO Pharmaceuticals, LLC$907
- Travere Therapeutics, Inc.$772
- Akebia Therapeutics Inc$663
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Calliditas Therapeutics US Inc. | 60 | $1,247 |
| Bayer | 66 | $1,165 |
| AstraZeneca(2 entities) | 50 | $915 |
| OPKO Pharmaceuticals, LLC | 59 | $907 |
| Travere Therapeutics, Inc. | 75 | $772 |
| Akebia Therapeutics Inc | 37 | $663 |
| Amgen(2 entities) | 30 | $648 |
| Novartis | 23 | $504 |
| Vifor Pharma, Inc. | 28 | $477 |
| Daiichi Sankyo Inc. | 18 | $415 |
| GSK | 14 | $347 |
| Boehringer Ingelheim | 20 | $326 |
| Mallinckrodt Hospital Products Inc. | 7 | $262 |
| Otsuka America Pharmaceutical, Inc. | 8 | $206 |
| Fresenius USA Marketing, Inc. | 12 | $202 |
| ANI Pharmaceuticals, Inc. | 5 | $113 |
| Nxstage Medical, Inc. | 2 | $95 |
| Aurinia Pharma U.S., Inc. | 4 | $70 |
| Mallinckrodt Enterprises LLC | 2 | $58 |
| Ardelyx, Inc. | 3 | $51 |
| Pharmacosmos Therapeutics Inc. | 2 | $47 |
| Novo Nordisk | 2 | $46 |
| Medtronic | 2 | $39 |
| Scpharmaceuticals Inc. | 2 | $37 |
| AbbVie | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| Sanofi | 1 | $16 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$9,680 in reported general payments places this provider in the 70th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Shawnee
- Michael LambertShawnee$639
- Dennis RossWichita$2.1M
- Jany MoussaWichita$793K
- Reem MustafaKansas City$569K
- Aditi GuptaKansas City$547K
- Alan YuKansas City$380K
- Kerri McGrealKansas City$368K
- Patrick FluckHutchinson$217K
- Ellen McCarthyKansas City$183K
- Lisa WeberWichita$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.